Stockholders of Aura Biosciences (NASDAQ:AURA) approved two proposals at a special virtual meeting held Aug. 5, 2026, including an increase in the company’s authorized common shares and an amendment to its equity incentive plan. Natalie Holles, Aura Biosciences’ chief executive officer and president, called the meeting to order and said it was conducted under the […]